CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The CoV2Ag assay is for in vitro diagnostic use in the qualitative detection of SARS-CoV-2 in nasopharyngeal swab and nasal swab specimens within the first seven days of symptom onset, or from asymptomatic individuals. The test has been submitted to the FDA for emergency use authorization.
Siemens Healthineers, 888-826-9702
Pages: 1 2